Novo Nordisk

The healthcare sector is shifting as legacy blockbusters face competition from low-cost generics while new chronic care treatments…

On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days…

New Delhi: The Delhi High Court on Tuesday asked Sun Pharma Laboratories to take its prior approval before…

This article first appeared on GuruFocus. Amazon.com Inc. (AMZN, Financials), the e-commerce and cloud-computing company, is expanding its…

Quick Read LLY raised 2026 guidance to $82B-$85B as Mounjaro and Zepbound surged, while NVO guided to an…

A recent high-profile court judgment halting a Pretoria pharmacy from selling GLP-1 drugs at scale has seemingly done…

Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…

Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of…

Johannesburg: Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa…

The short, but glib, answer to the headline question posed for Viking Therapeutics (NASDAQ: VKTX) investors is “no,”…

Pharmacies in the UK are “bracing themselves” for a surge in patients starting weight loss drugs as the…

FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…

AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?